Testing effectiveness (Phase 2)UnknownNCT03595995What this trial is testingTrial to Evaluate the Safety and Efficacy of UB-621Who this might be right forGenital Herpes United BioPharma 80
Not applicableStudy completedNCT00946556What this trial is testingExamining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the CervixWho this might be right forHerpes Simplex Type Two InfectionHIV Infections University of Toronto 30
Not applicableStudy completedNCT01112956What this trial is testingSerologic Assays for the Diagnosis of Herpes Simplex Virus Type 2Who this might be right forGenital Herpes Centers for Disease Control and Prevention 2,500
Testing effectiveness (Phase 2)UnknownNCT04714060What this trial is testingUB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the GenitalsWho this might be right forRecurrent Genital Herpes UBP Greater China (Shanghai) Co., Ltd 44
Early research (Phase 1)Active Not RecruitingNCT05432583What this trial is testingA Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes LesionsWho this might be right forGenital Herpes Simplex Type 2 BioNTech SE 318
Early research (Phase 1)Ended earlyNCT00003567What this trial is testingGene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific Case Comprehensive Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT00164424What this trial is testingEpisodic Acyclovir Therapy for Genital UlcersWho this might be right forHIV InfectionsUlcerHerpes Simplex Centers for Disease Control and Prevention 613
Early research (Phase 1)Enrolling By InvitationNCT07330440What this trial is testingA Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-VaccinationWho this might be right forGenital Herpes Changchun BCHT Biotechnology Co. 144
Large-scale testing (Phase 3)Study completedNCT02570126What this trial is testingA Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.Who this might be right forChicken-pox Illness (Varicella Virus Disease)Chickenpox GlaxoSmithKline 1,236
Not applicableStudy completedNCT02986802What this trial is testingComparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy OutcomesWho this might be right forHSV-2 InfectionPreTerm BirthPregnancy Complications Kaiser Permanente 89,132
Testing effectiveness (Phase 2)Study completedNCT02030301What this trial is testingSafety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsWho this might be right forGenital Herpes Simplex Type 2 Vical 165
Not applicableStudy completedNCT01043081What this trial is testingSexually Transmitted Infections Among African American Women Who Have Sex With WomenWho this might be right forSexually Transmitted InfectionsHIV Infections University of Mississippi Medical Center 300
Not applicableStudy completedNCT04950712What this trial is testingAn Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.Who this might be right forHerpes Genitalis GlaxoSmithKline 537
Testing effectiveness (Phase 2)Study completedNCT01687595What this trial is testingBiological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital HerpesWho this might be right forHerpes Simplex Type 2 Agenus Inc. 80
Early research (Phase 1)Study completedNCT01453075What this trial is testingEvaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)Who this might be right forChronic Hepatitis C Infection VA Office of Research and Development 31
Not applicableWithdrawnNCT04294030What this trial is testingNOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2Who this might be right forHSV-2 InfectionHerpes Simplex Virus Infection NOWDiagnostics, Inc.
Post-approval studies (Phase 4)Study completedNCT00723229What this trial is testingTrial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 ReactivationWho this might be right forGenital Herpes University of Washington 48
Early research (Phase 1)Study completedNCT00331032What this trial is testingVivaGel™ in Healthy Young WomenWho this might be right forHerpes Simplex II National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableStudy completedNCT00899496What this trial is testingLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsWho this might be right forCancer Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT01667341What this trial is testingSafety and Immunogenicity Study of Therapeutic HSV-2 VaccineWho this might be right forGenital Herpes Simplex Type 2 Genocea Biosciences, Inc. 143